BETAPACE- sotalol hydrochloride tablet
BETAPACE AF- sotalol hydrochloride tablet United States - English - NLM (National Library of Medicine)

betapace- sotalol hydrochloride tablet betapace af- sotalol hydrochloride tablet

covis pharma us, inc - sotalol hydrochloride (unii: hec37c70xx) (sotalol - unii:a6d97u294i) - sotalol hydrochloride 80 mg - betapace/betapace af is indicated for the treatment of documented, life-threatening ventricular arrhythmias, such as sustained ventricular tachycardia (vt). limitation of use: betapace/betapace af has not been shown to enhance survival in patients with life-threatening ventricular arrhythmias. betapace/betapace af is indicated for the maintenance of normal sinus rhythm (delay in time to recurrence of afib/afl) in patients with highly symptomatic afib/afl who are currently in sinus rhythm. limitation of use: because betapace/betapace af can cause life-threatening ventricular arrhythmias, reserve its use for patients in whom afib/afl is highly symptomatic. patients with paroxysmal afib that is easily reversed (by valsalva maneuver, for example) should usually not be given betapace/betapace af. betapace/betapace af is contraindicated in patients with: for the treatment of afib/afl, betapace/betapace af is also contraindicated in patients with: both the untreated underlying condition in pregnancy and the use of s

BETAPACE AF sotalol hydrochloride tablet United States - English - NLM (National Library of Medicine)

betapace af sotalol hydrochloride tablet

bayer healthcare pharmaceuticals inc. - sotalol hydrochloride (unii: hec37c70xx) (sotalol - unii:a6d97u294i) - sotalol hydrochloride 80 mg

Sotalol 40mg tablets United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

sotalol 40mg tablets

alliance healthcare (distribution) ltd - sotalol hydrochloride - oral tablet - 40mg